Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00250783
NCT00250783
Completed
Not Applicable

Pre-Clinical Models in Gynecological Tumors: A Tissue Repository

University of New Mexico1 site in 1 country26 target enrollmentJuly 2002
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsEndometrial NeoplasmsUterine Neoplasms

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endometrial Neoplasms
Sponsor
University of New Mexico
Enrollment
26
Locations
1
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to provide a repository for long-term storage of endometrial cancer tumor and normal tissue, ascites and serum. This material will be used in studies to better understand the molecular biology of endometrial cancer.

Detailed Description

BACKGROUND AND RATIONALE This protocol will create a central repository for banking tumor and other tissues as well as serum from patients with uterine corpus tumors. In addition, this protocol will also serve as a central repository for serum and tissue to healthy post-menopausal and peri-menopausal controls. There will be an "internal" bank. The internal bank will have samples available to UNM investigators.

Registry
clinicaltrials.gov
Start Date
July 2002
End Date
January 2008
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •All patients undergoing hysterectomy, or who have endometrial cancer, and are under routine surveillance.
  • •Patients may have received prior hormonal, cytotoxic chemotherapy, irradiation or surgical therapy.
  • •Healthy post-menopausal and peri-menopausal women.
  • •A consent form must be signed by the patient prior to study entry.

Exclusion Criteria

  • •Study Patients:
  • •Patients who do not have primary uterine corpus tumors.
  • •Patients with less than one gram of tumor tissue available to procurement.
  • •Patients unwilling to have their medical records reviewed for height, weight, and general medical history (see attached data sheets).

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Construction of Gynecological Tumor OrganoidsGynecologic CancerOrganoid
NCT06155370Peking Union Medical College Hospital200
Unknown
Not Applicable
Tissue Bank of Biological Specimens From Patients With Gynecologic DiseaseEndometrial NeoplasmsUterine Cervical NeoplasmsOvarian NeoplasmsLeiomyoma
NCT00299481U.S. Army Medical Research and Development Command7,000
Recruiting
Not Applicable
Patient Derived Preclinical ModelsCancer
NCT05324553Mayo Clinic50
Unknown
Not Applicable
Endometrial Cancer International DatabaseEndometrial Cancer
NCT04787159Assiut University1,000
Completed
Not Applicable
Collecting Tumor Samples From Patients With Gynecological TumorsBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedChildhood Embryonal RhabdomyosarcomaChildhood Malignant Ovarian Germ Cell TumorEndometrioid Stromal SarcomaGestational Trophoblastic TumorMalignant MesotheliomaMalignant Ovarian Epithelial TumorMelanomaNeoplasm of Uncertain Malignant PotentialOvarian Brenner TumorOvarian Clear Cell CystadenocarcinomaOvarian Serous CystadenocarcinomaPaget Disease of the VulvaRecurrent Cervical CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Ovarian Germ Cell TumorRecurrent Primary Peritoneal CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Vaginal CarcinomaRecurrent Vulvar CarcinomaStage I Ovarian CancerStage I Uterine Corpus CancerStage I Vaginal CancerStage I Vulvar CancerStage IA Cervical CancerStage IA Fallopian Tube CancerStage IA Ovarian CancerStage IA Ovarian Germ Cell TumorStage IB Cervical CancerStage IB Fallopian Tube CancerStage IB Ovarian CancerStage IB Ovarian Germ Cell TumorStage IC Fallopian Tube CancerStage IC Ovarian CancerStage IC Ovarian Germ Cell TumorStage II Ovarian CancerStage II Uterine Corpus CancerStage II Vaginal CancerStage II Vulvar CancerStage IIA Cervical CancerStage IIA Fallopian Tube CancerStage IIA Ovarian CancerStage IIA Ovarian Germ Cell TumorStage IIB Cervical CancerStage IIB Fallopian Tube CancerStage IIB Ovarian CancerStage IIB Ovarian Germ Cell TumorStage IIC Fallopian Tube CancerStage IIC Ovarian CancerStage IIC Ovarian Germ Cell TumorStage III Borderline Ovarian Surface Epithelial-Stromal TumorStage III Cervical CancerStage III Uterine Corpus CancerStage III Vaginal CancerStage III Vulvar CancerStage IIIA Fallopian Tube CancerStage IIIA Ovarian CancerStage IIIA Ovarian Germ Cell TumorStage IIIA Primary Peritoneal CancerStage IIIB Fallopian Tube CancerStage IIIB Ovarian CancerStage IIIB Ovarian Germ Cell TumorStage IIIB Primary Peritoneal CancerStage IIIC Fallopian Tube CancerStage IIIC Ovarian CancerStage IIIC Ovarian Germ Cell TumorStage IIIC Primary Peritoneal CancerStage IV Borderline Ovarian Surface Epithelial-Stromal TumorStage IV Fallopian Tube CancerStage IV Ovarian CancerStage IV Primary Peritoneal CancerStage IV Uterine Corpus CancerStage IVA Cervical CancerStage IVA Vaginal CancerStage IVB Cervical CancerStage IVB Vaginal CancerStage IVB Vulvar CancerUterine Corpus CancerUterine Corpus LeiomyosarcomaVulvar Squamous Cell Carcinoma
NCT00897442Gynecologic Oncology Group275